Mar 28, 2019
Global COPD Drugs Market is projected to display robust growth represented by a CAGR of 2.47% during 2018 - 2023
Mar 27, 2019
Global COPD Drugs Market by Drug Type, Pipeline Drugs, Region, and Country - Forecast to 2023
Mar 01, 2019
United States Inhalation Systems Market, 2024 - Upsurge in the Demand for Home-Care Therapeutic Devices
Feb 21, 2019
New PhRMA Report Finds 130 Medicines in Development for Asthma, Allergies and Other Respiratory Diseases
Jan 17, 2019
Gala Enrolls First Subject at Temple Lung Center as Part of the US Early Feasibility Trial of RheOx(TM) for Chronic Bronchitis in the United States
Nov 27, 2018
Theravance Biopharma Announces First Subject Dosed in Phase 1 Clinical Trial of TD-8236, a Novel Inhaled pan-JAK Inhibitor
Nov 21, 2018
Mediaplanet and Grammy Award Winning Artist Jewel Work to Bring Awareness to Lung Cancer and Respiratory Conditions
Nov 09, 2018
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI(TM) (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease
Nov 05, 2018
Gala Enrolls First Subjects in an Early Feasibility Study of RheOx(TM) for Chronic Bronchitis in the United States
Oct 23, 2018
How Lung Health Institute is Addressing an Age-Old Stigma Stalling Progress in the Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Oct 11, 2018
FDA Approves Stiolto® Respimat® Supplemental New Drug Application (sNDA) to Add Data on COPD Exacerbation Reduction
Oct 04, 2018
Triple dual therapy significantly improves lung function, quality of life in COPD patients
Sep 18, 2018
RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis
Sep 17, 2018
Pulmatrix to present pre-clinical data on PUR1800 (RV1162) at the European Respiratory Society International Congress
Sep 17, 2018
Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI(TM) (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
Sep 17, 2018
Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Aug 10, 2018
Novel Drugs and Smart Devices for Respiratory Disorders, 2018-2030 - Evaluation of Approx. 135 Novel Drug Candidates Across Various Stages of Development
Aug 08, 2018
Data From First-In-Human RheOx(TM) Bronchial Rheoplasty Trial to be Presented at the European Respiratory Society
Jul 12, 2018
Gala Therapeutics Receives FDA IDE Approval for a US Early Feasibility Study of Its RheOx(TM) System to Treat Chronic Bronchitis
Jun 26, 2018
Novel Drugs and Smart Devices for Respiratory Disorders, 2018 - 2030